Considering the burden of diabetes in general on dogs and their caretakers, and in particular the added burden caused by comorbidities of the GI tract (including interfering with insulin therapy, added cost, etc.)any reduction of that burden might have important long‐term benefits to the survival and quality of life of the diabetic dog. This evidence concerns the gene INS and diabetes mellitus.